Skip to content

Screening for Occult Malignancy in Idiopathic Venous Thromboembolism

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00361647
Enrollment
Unknown
Registered
2006-08-08
Start date
2006-01-31
Completion date
Unknown
Last updated
2008-06-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Venous Thromboembolism

Brief summary

Prospective controlled randomized study. Aim of this study is to assess the feasibility and sensitivity of CT scanning of the thorax, abdomen and pelvis for the detection of occult cancer in patients with idiopathic venous thromboembolism. Patients presenting with acute idiopathic venous thromboembolism, free from already known cancer and in whom a routine battery screening has excluded the presence of cancer, are randomized to receive either a CT scanning of the thorax, abdomen and pelvis (completed by mammography if not already performed in the past year, and by gastroscopy and/or colonoscopy in patients with positive hemoccult) or a diagnostic programme freely decided by attending physicians. Patients of either group in whom the search for cancer is negative are followed-up for two years to register the development of clinically symptomatic malignant disease. The rate of cancer detection and that of cancer development are compared between the two study groups.

Interventions

PROCEDUREDiagnostic screening for occult malignancy

Sponsors

University of Padova
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
DIAGNOSTIC
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum

Inclusion criteria

* idiopathic venous thromboembolism

Exclusion criteria

* cancer already known or shown by routine battery tests * previous venous thromboembolism * geographic inaccessibility for long-term follow-up * allergy to contrast medium * refusal of informed consensus

Countries

Italy

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 12, 2026